People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TerrAscend Corp. | — | Other | Series B | $135.5M | $356.9M | 2019 |
| Heron Therapeutics, Inc. /De/ | — | Biotechnology | Series C | $117.2M | $382.4M | 2023 |
Craig Collard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Craig Collard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| CRAIG JOHNSON | 1 | 16 |
| Matthew Johnson | 1 | 9 |
| Robert Zerbe | 1 | 5 |
| Paul Goddard | 1 | 4 |
| John Barr | 1 | 3 |
| Jason Ackerman | 1 | 3 |
| Kevin Kotler | 1 | 3 |
| Kevin Tang | 1 | 3 |
| Brian Feldman | 1 | 2 |
| Gregory Turnbull | 1 | 2 |
| JOHN B. WHELAN | 1 | 2 |
| Heather Molloy | 1 | 2 |
| John Whelan | 1 | 2 |
| Jason Wild | 1 | 2 |
| BARRY D. QUART | 1 | 2 |
| Christian Waage | 1 | 2 |
| Michael Nashat | 1 | 1 |
| Keith Stauffer | 1 | 1 |
| Lisa Swartzman | 1 | 1 |
| Joanna Halligan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.